Address
Other Office
545 Steamboat Road
Greenwich, CT 06830
United States
Recent investment activity
Corporate information
Overview
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality of life, and/or reduce system costs. We invest in both privately held and publicly traded companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.8 billion across four funds and demonstrated an ability to source, manage, and exit attractive investments across multiple market cycles. Our venture growth strategy is rooted in building a balanced portfolio of clinical-stage and commercial-stage companies with clinically de-risked assets, favorable valuations relative to risk profile, and attractive expected returns within three to five years from initial investment. Longitude Capital seeks to identify new investment opportunities by tapping into our broad network of industry relationships or through the execution of intensive thematic research into emerging therapeutic areas or industry sub-sectors. We utilize a variety of investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, open market purchases, royalties, and other equity and equity-linked instruments.
Funds managed
Fund | Type | Vintage | Currency | Committed capital |
---|---|---|---|---|
Longitude Venture Partners II | Venture | 2012 | USD | 385,000,000 |
Longitude Venture Partners I | Venture | 2008 | USD | 325,000,000 |
Funding rounds
Selected investments
Displaying 1 - 20 of 20Company | Profile | Country | Date Sort ascending | Funding | ||
---|---|---|---|---|---|---|
Tricida Inc | Series C led the round | |||||
BaroNova Inc | Developer of non-surgical devices to induce weight loss | Series D led the round | ||||
CardioDx Inc | Series F Initial investment | |||||
Aptus Endosystems Inc | Series B | |||||
PixelOptics Inc | Develops, manufactures, and markets electronic spectacle lenses | N/A | ||||
MAP Pharmaceuticals Inc | Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. | N/A | ||||
Ablation Frontiers Inc | Medical device company that has developed and marketed cardiac ablation devices. | N/A | ||||
Threshold Pharmaceuticals Inc | N/A | |||||
Sugen Inc | Biopharmaceutical company that discovered and developed small molecule drugs used for diseases such as cancer and diabetes. | N/A | ||||
Sequenom Inc | Biotechnology tools and diagnostics company. | N/A | ||||
Sadra Medical Inc | N/A | |||||
Prestwick Pharmaceuticals Inc | A specialty pharmaceutical company engaged in the development and marketing of drugs for diseases of the CNS. | N/A | ||||
ORATEC Interventions Inc | N/A | |||||
Insulet Corp | N/A | |||||
Eyetech Pharmaceuticals Inc | Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. | N/A | ||||
eyeonics Inc | N/A | |||||
Embolic Protection Inc | N/A | |||||
CryoVascular Systems Inc | Medical device company for peripheral arterial disease. | N/A | ||||
Codexis Inc | Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. | N/A | ||||
Align Technology Inc | N/A |